President of Kobayashi Pharmaceutical standing down after damning report said company failed to act with sufficient urgency after alarm was raised in January
The chairman and president of a major Japanese dietary supplement maker is to resign, as the company probes up to 80 deaths potentially linked to dietary supplements meant to lower cholesterol.
Kobayashi Pharmaceutical, a household name in Japan, is at the centre of heath fears linked to its over-the-counter tablets containing red yeast rice, which is fermented with a mould culture.
About Author
More Stories
Corporations using ‘ineffectual’ carbon offsets are slowing path to ‘real zero’, more than 60 climate scientists say
High-flying life of Australia’s birds revealed in new detail – thanks to weather radars
Labor lost Queensland election partly because it was obsessed with the Greens, Chandler-Mather says